These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16817763)

  • 21. A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity.
    Dong H; Lu Y; Zhang Y; Mu S; Wang N; Du P; Zhi X; Wen X; Wang X; Sun S; Zhang Y; Guo H
    J Virol; 2021 Jul; 95(16):e0017721. PubMed ID: 34011545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Construction and identification of a recombinant PRRSV expressing protective antigens of type O foot-and-mouth disease virus].
    Tong W; Xu Y; Zhou Y; Jiang Y; Zhang S; Wang Y; Zhu J; Yu L; Sun J; Chen H; Tong G
    Sheng Wu Gong Cheng Xue Bao; 2012 Dec; 28(12):1431-40. PubMed ID: 23593867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor.
    Du Y; Jiang P; Li Y; He H; Jiang W; Wang X; Hong W
    Vaccine; 2007 Nov; 25(49):8209-19. PubMed ID: 17980939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a recombinant vaccine against foot and mouth disease utilizing mutant attenuated Listeria ivanovii strain as a live vector.
    Mahdy SE; Sijing L; Lin S; Xiang Z; Hao-Tai C; Xiaofang P; Chuan W
    J Virol Methods; 2019 Nov; 273():113722. PubMed ID: 31422118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.
    Du Y; Li Y; He H; Qi J; Jiang W; Wang X; Tang B; Cao J; Wang X; Jiang P
    J Virol Methods; 2008 Apr; 149(1):144-52. PubMed ID: 18294705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promising MS2 mediated virus-like particle vaccine against foot-and-mouth disease.
    Dong YM; Zhang GG; Huang XJ; Chen L; Chen HT
    Antiviral Res; 2015 May; 117():39-43. PubMed ID: 25676866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine.
    Pena L; Moraes MP; Koster M; Burrage T; Pacheco JM; Segundo FD; Grubman MJ
    Vaccine; 2008 Oct; 26(45):5689-99. PubMed ID: 18762225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The VP1 G-H loop hypervariable epitope contributes to protective immunity against Foot and Mouth Disease Virus in swine.
    Fernandez-Sainz I; Gavitt TD; Koster M; Ramirez-Medina E; Rodriguez YY; Wu P; Silbart LK; de Los Santos T; Szczepanek SM
    Vaccine; 2019 Jun; 37(26):3435-3442. PubMed ID: 31085001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
    Zhou G; Wang H; Wang F; Yu L
    Res Vet Sci; 2013 Jun; 94(3):796-802. PubMed ID: 23267820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a bovine enterovirus-based vector expressing a foot-and-mouth disease virus epitope.
    Chu JQ; Lee YJ; Park JN; Kim SM; Lee KN; Ko YJ; Lee HS; Cho IS; Kim B; Park JH
    J Virol Methods; 2013 Apr; 189(1):101-4. PubMed ID: 23391822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Construction and identification of recombinant BHV-1 expressing foot and mouth disease virus VP1 gene].
    Ren X; Xue F; Zhu Y; Tong G; Wang Y; Feng J; Zu L; Li J; Shi H; Gao Y
    Wei Sheng Wu Xue Bao; 2009 May; 49(5):677-82. PubMed ID: 19637579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel mucosal vaccine against foot-and-mouth disease virus induces protection in mice and swine.
    Song H; Wang Z; Zheng D; Fang W; Li Y; Liu Y; Niu Z; Qiu B
    Biotechnol Lett; 2005 Nov; 27(21):1669-74. PubMed ID: 16247672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
    Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
    J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
    Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
    Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopes.
    Yang CD; Liao JT; Lai CY; Jong MH; Liang CM; Lin YL; Lin NS; Hsu YH; Liang SM
    BMC Biotechnol; 2007 Sep; 7():62. PubMed ID: 17900346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
    Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
    Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of immune responses against FMD by a DNA vaccine encoding the FMDV/O/IRN/2007 VP1 gene and the conventional inactivated vaccine in an animal model.
    Sedeh FM; Soleimanjahi H; Jalilian A; Mahravani H
    Virol Sin; 2012 Oct; 27(5):286-91. PubMed ID: 23001482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Construction of recombinant adenovirus expressing capsid protein of serotype O foot-and-mouth disease virus and analysis of its immunogenicity].
    Wang C; Zhang L; Liu X; Zhou P; Pan L; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2022 May; 38(5):1824-1836. PubMed ID: 35611731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the immune response elicited by vaccination with viral vectors encoding FMDV capsid proteins and boosted with inactivated virus.
    Romanutti C; D'Antuono A; Palacios C; Quattrocchi V; Zamorano P; La Torre J; Mattion N
    Vet Microbiol; 2013 Aug; 165(3-4):333-40. PubMed ID: 23683999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.